96 related articles for article (PubMed ID: 28315489)
1. Effect of angiotensin 2 receptor blockers on chronic obstructive lung disease mortality: A retrospective cohort study.
Paulin P; Maritano Furcada J; Ungaro CM; Bendelman G; Waisman GD; Castro HM; Giunta DH; Ferreyro BL
Pulm Pharmacol Ther; 2017 Jun; 44():78-82. PubMed ID: 28315489
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic obstructive pulmonary disease on patients with aortic aneurysms: a nationwide retrospective cohort study in Taiwan.
Liao KM; Chen CY
BMJ Open; 2017 Sep; 7(9):e015806. PubMed ID: 28871015
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
4. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
[TBL] [Abstract][Full Text] [Related]
5. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
[TBL] [Abstract][Full Text] [Related]
6. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
[TBL] [Abstract][Full Text] [Related]
8. Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Lin JW; Chang CH; Caffrey JL; Wu LC; Lai MS
Hypertension; 2014 May; 63(5):968-76. PubMed ID: 24516110
[TBL] [Abstract][Full Text] [Related]
9. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.
Hayes D; Black SM; Tobias JD; Mansour HM; Whitson BA
COPD; 2016; 13(1):50-6. PubMed ID: 26366936
[TBL] [Abstract][Full Text] [Related]
12. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
14. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
15. Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.
Ekström MP; Hermansson AB; Ström KE
Am J Respir Crit Care Med; 2013 Apr; 187(7):715-20. PubMed ID: 23328521
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
Ho TW; Huang CT; Ruan SY; Tsai YJ; Lai F; Yu CJ
PLoS One; 2017; 12(4):e0175794. PubMed ID: 28410410
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Chae SC;
Korean J Intern Med; 2016 Mar; 31(2):267-76. PubMed ID: 26701233
[TBL] [Abstract][Full Text] [Related]
19. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes.
Camillo CA; Langer D; Osadnik CR; Pancini L; Demeyer H; Burtin C; Gosselink R; Decramer M; Janssens W; Troosters T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2671-2679. PubMed ID: 27822029
[TBL] [Abstract][Full Text] [Related]
20. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
